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Inflammatory myofibroblastic tumor has been defined as a histologically distinctive lesion with uncertain behaviour.
The term inflammatory myofibroblastic tumor more commonly referred to as “pseudostumor ”, denotes a
pseudosarcomatous inflammatory lesion that contains spindle cells, myofibroblasts, plasma cells, lymphocytes and
histiocytes. It exhibits a variable biological behavior that ranges from frequently benign lesions to more aggressive
variants. Inflammatory myofibroblastic tumor mostly occurs in the soft tissue of children and young adults, and the
lungs are the most commonly affected site, but it has been recognized that any anatomic localization can be
involved. Inflammatory myofibroblastic tumors in adults are very rare, especially in the stomach. We present a case
of a 43-year old woman with primary inflammatory myofibiroblastic tumor in the stomach and a review of the
literature.
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Inflammatory myofibroblastic tumor (IMT) has been
defined as a histologically distinctive lesion of uncertain be-
havior. It has also been previously known as inflammatory
pseudotumor, plasma cell granuloma, inflammatory myofi-
broblastoma, and inflammatory myofibrohistiocytic prolif-
eration. IMT frequently recurs and rarely metastasizes [1].
It seems that a large proportion of these lesions are true
mesenchymal neoplasms and the term IMT more com-
monly referred to as “pseudotumor”, refers to a pseudo-
sarcomatous inflammatory lesion that mostly occurs in
the soft tissue of children and young adults, and contains
spindle cells, myofibroblasts, plasma cells, lymphocytes
and histiocytes [2,3]. The pathogenesis of IMT remains
unclear, although various allergic, immunologic, and infec-
tious mechanisms have been postulated [4]. IMT rarely
occurs in adult persons, particularly in the stomach [2,3].
The previously described cases of primary gastric IMTs
were in the form of case reports or small series [5-8]. Here* Correspondence: m.bjelovic@med.bg.ac.rs
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reproduction in any medium, provided the orwe present the case of a primary gastric IMT in an adult
woman and a review of the literature.Case presentation
A 43-year old caucasian woman was presented with
gastrointestinal symptoms e.g. epigastric pain, nausea and
pyrosis. She had had gastrointestinal symptoms for 2 years,
a positive medical history of a c-section for a year, and a
laparoscopic cholecystectomy 2 years before this consult-
ation. On admission her body mass index (BMI) was
37,2 kg/m2, and she had Karnofsky score of 100%. Physical
examination showed mild abdominal tenderness in the
epigastric region, but no palpable abdominal mass. Her
laboratory analyses were unremarkable. The chest X-ray
film was normal. Round, sharply contoured filling defect,
situated on the lesser curvature of the stomach, near the
angular incisure, approximately 2.5 cm in diameter, was
demonstrated by a double-contrast bariummeal (Figure 1).
Endoscopic ultrasound (EUS) showed an oval hypoechoic
mass, 25 × 17 mm in diameter, arising from the mus-
cularis propria layer (Figure 2). Abdominal computed
tomography (CT) demonstrated the hyperattenuating
focal polypoid posterior wall thickening of the gastricl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Double-contrast barium meal of the stomach showing
the inflammatory myofibroblastic tumor (IMT). A round, sharply
contoured filling defect was identified, situated on the lesser
curvature of the stomach, near the angular incisure, approximately
2.5 cm in diameter.
Figure 3 Abdominal computed tomography (CT) scan of the
stomach showing the inflammatory myofibroblastic tumor
(IMT). Hyperattenuating, focal, polypoid posterior wall thickening
was identified near the angular incisure of the stomach.
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metastatic disease (Figure 3). Upper flexible endoscopy
demonstrated a round, white-gray, sessile and hard lesion,
with surrounding distal flattening infiltration of the gastric
wall. Lesion was in a part covered with fibrin, andFigure 2 Endoscopic ultrasound (EUS) of the inflammatory
myofibroblastic tumor (IMT). An oval hypoechoic mass, 25 × 17 mm
in diameters was identified arising from the muscularis propria layer.localized on the lesser curvature below the angular
incisure (Figure 4). There was no active, or any sign of re-
cent bleeding. Multiple endoscopic biopsy samples were
taken. Histopathological evaluation of the biopsy samples
demonstrated unclear hypercelullar proliferation consisting
of mesenchymal and inflammatory cells. However, focal
atypia gave rise to suspicion of sarcomatous or even ana-
plastic cell neoplasia with unclear histogenesis.
Due to gastric tumor with unclear tumor histology, sur-
gical excision was suggested. The patient underwent an
exploratory laparotomy. During surgery tumor formation
was found in the distal part of the stomach closer to small
curvature. The tumor mass involved the entire thickness
of the gastric wall. There were no signs of adjacent organsFigure 4 Upper flexible endoscopy of the inflammatory
myofibroblastic tumor (IMT). A round, white-gray, sessile and hard
lesion was identified, with surrounding, distal, flattening infiltration of
the gastric wall. The lesion was partially covered with fibrin, and was
localized below the lesser curvature in the distal part of the stomach.
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D2 lymph node dissection and Roux-en-Y reconstruction
was performed. Early postoperative course was uneventful
and patient was discharged from the hospital 8 days follow-
ing the surgery. Macroscopic examination of the resected
portion of the stomach revealed a well demarcated tumor
mass in the distal part of the stomach, 60 × 40 mm in diam-
eter, with superficial polypoid protrusion, which on cut sur-
face resembled an ill defined whitish nodular fraction
measuring 25 × 17 × 17 mm. Histologically, there was an
ill-defined proliferation composed mostly of spindle-shaped
mesenchymal cells admixed with diffusely scattered inflam-
matory cells. The mitotic count was 1/10 high power fields
(HPF), and Ki-67 labeling index was estimated at 8%. Cellu-
lar atypia was focal and seemed reactive, as mostly observed
in the vicinity of ulcerative superficial portions. There was
no tumor necrosis. Lymph nodes found in the perigastric
region and celiac trunk all tested negative for tumor. Con-
trary to the inflammatory fibroid polyp, the lesion had less
eosinophils and fibroses but more lymphoid cell infiltrates.
Moreover, a regular vascular pattern or “perivascular cuff-
ing” was not observed, which is regarded as a feature ofFigure 5 Findings on histology of gastric inflammatory myofibroblastic
inflammatory cells with (b) focal mucoid change. (c) Characteristic loosely orga
infiltration and (d) focal mixed epithelioid and spindle cell presentation. Immu
(f) diffuse strong cytoplasmic anaplastic lymphoma kinase (ALK) protein immuinflammatory fibroid polyps, rather than inflammatory
myofibroblastic tumors. On immunohistochemistry, tumor
cells showed positive immunoreactivity for vimentin, al-
though only focal smooth muscle actin (SMA) and sparse
desmin immunoexpression, while remainnig negative for
pan-cytoceratin, c-kit, CD 34 and S-100. These findings
and evident immunoexpression of anaplastic lymphoma
kinase (ALK) protein were consistent with an IMT originat-
ing from the gastric wall. Having in mind the positive
immunoreactivity for ALK and on consulting referent data
it was concluded that the particular IMT might have recur-
rent potential and possible aggressive prognosis, thus repre-
senting uncertain metastatic biological behavior (Figure 5).
The patient was without symptoms over 24 months of
follow-up. During this period the US, CT and upper flex-
ible endoscopy showed no signs of tumor recurrence or
metastatic disease.
Conclusion
IMT is a rare lesion, considered to be morphologic ex-
pression of reactive, reparative, infective and neoplastic
processes [9]. There has been debate as to whethertumor (IMT). (a) Mucosal and transmural infiltration of mesenchymal and
nized fascicles of myofibroblastic cells admixed with diffuse inflammatory
nohistochemistry showed (e) sparse desmin immunoexpression and
noexpression with some perinuclear intensification.
Bjelovic et al. World Journal of Surgical Oncology 2013, 11:35 Page 4 of 6
http://www.wjso.com/content/11/1/35IMT is a tumor or inflammation, and also whether is
benign or malignant. It is locally recurrent, however
it rarely metastasizes [1]. IMT is histopathologically
composed of myofibroblastic spindle cells with inflam-
matory cell infiltrate of plasma cells, lymphocytes and
eosinophiles [1]. It is mainly seen in children and
young adults, and the lungs are the most commonly
affected site, but it has been recognized that any ana-
tomic localization can be involved. The first abdom-
inal localization was described in liver by Pack and
Baker in 1953 [10]. Primary gastric IMT in adults are
very rare [5].
We presented the case of a 43-year old caucasian
woman with prior medical history of a c-section a year,
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NED, no evidence of disease.prior to this medical consultation. It has been suggested
that IMT is a reactive, reparative lesion which occurs
after trauma or surgery (Table 1), [6,11].
In this case, due to relatively small tumor, patient had
dyspeptic symptoms for two years. However, IMT clin-
ical presentation varies depending on its anatomical
localization in the stomach and size (Table 1).
Even with a thorough diagnostic workup, which included
CT, US, EUS, laboratory analyses, upper flexible endoscopy
with biopsy in this case, it was difficult to make an accurate
preoperative tumor diagnosis. In most cases IMT features
mimic malignancy on upper flexible endoscopy and radio-
logical imaging. For that reason, most IMT cases require
surgical exploration and complete resection to obtain an
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static disease, a radical surgical procedure was performed
including a subtotal gastrectomy with D2 lymph node dis-
section and Roux-en-Y reconstruction. A complete surgi-
cal resection remains the only proven mode of cure, and
is proposed as the first line of treatment in all IMT cases
[12]. Types of surgical procedures used in other cases of
primary gastric IMTs depended on tumor localization and
size as well as general condition of patients (Table 1).
In the given case, pathology revealed a clearly demar-
cated tumor mass located in the distal part of the stom-
ach which involved full thickness of the gastric wall,
without any signs of adjacent organs infiltration. The
lymph nodes were all negative for tumor. The histo-
logical features of the tumor included myofibroblastic
proliferation and a varying degree of inflammatory cells
mainly consisting of lymphocytes, histiocytes and plasma
cells. Similar histological patterns were described in
other cases of primary gastric IMTs, (Table 1).
In this case the tumor cells showed a positive immun-
noreactivity with ALK protein. The presence of ALK
protein expression essentially serves as a surrogate mar-
ker for the translocation involving the ALK locus at
chromosome 2p23, hence excluding a reactive myofibro-
blastic proliferation. These results were suggestive of
IMT with possible aggressive prognosis and metastatic
potential. However, recently published data suggest that
ALK protein expression and epitheliod or round cell
morphology rather than other pathologic features correl-
ate well with the behavior. For those cases, the term
epithelioid inflammatory myofibroblastic sarcoma has
been proposed [13].
Within a year of a surgery, 15% to 37% cases of pri-
mary gastric IMT ended with tumor recurrence [14]. In
every primary gastric IMT case a long- term clinical,
radiological and laboratory follow-up was indicated. In
the presented case after 24 months of follow-up period
the patient was symptoms free, with no signs of tumor
recurrence or metastatic disease.Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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